» Articles » PMID: 31453503

Diagnosing Fibromyalgia in Rheumatoid Arthritis: The Importance of Assessing Disease Activity

Overview
Date 2019 Aug 28
PMID 31453503
Citations 5
Authors
Affiliations
Soon will be listed here.
Abstract

Objectives: This study aims to evaluate fibromyalgia syndrome (FMS) incidence based on 2010 American College of Rheumatology (ACR) criteria in rheumatoid arthritis (RA) patients and the association between FMS with disease activity, functional status and quality of life (QoL).

Patients And Methods: The study included 151 RA patients (32 males, 119 females; mean age 52.4±12.7 years; range 21 to 82 years) and 77 controls (13 males, 64 females; mean age 53.7±10.2 years; range 33 to 73 years). Individuals were classified into four groups based on presence of RA and FMS. Group 1 included patients with both RA and FMS (n=53), group 2 included patients with RA and without FMS (n=98), group 3 included controls with FMS (n=15), and group 4 included controls without FMS (n=62). Demographic characteristics, morning stiffness (MS), pain, Disease Activity Score 28 (DAS28), functional and QoL scores were compared among the groups.

Results: No significant differences were found between the four groups as regards the mean age and gender distribution (p>0.05). Higher pain, MS, DAS28, and QoL scores in the groups with FMS drew attention. While FMS was found in 8.1% of RA patients with remission, it was found in 53.9% of patients with active RA, and in 19.5% of controls.

Conclusion: Although FMS incidence in patients with RA was higher compared to controls without inflammatory disease, FMS evaluated with 2010 ACR diagnostic criteria was found to be common in the general population. DAS28 and inflammatory markers were higher in RA patients with FMS; thus, it has been concluded that sleep disorder and widespread pain caused by active disease may facilitate the diagnosis of FMS.

Citing Articles

Prevalence of comorbidities among patients with rheumatoid arthritis in the UAE: a case-control study.

Al-Saleh J, Ali Khan N, Zamani N, AlSaidi H, Rachidi W BMJ Open. 2024; 14(11):e086116.

PMID: 39532347 PMC: 11574516. DOI: 10.1136/bmjopen-2024-086116.


Clinical implications of seropositive and seronegative autoantibody status in rheumatoid arthritis patients: A comparative multicentre observational study.

Hammam N, El-Husseiny P, Al-Adle S, Samy N, Elsaid N, El-Essawi D Rheumatol Immunol Res. 2024; 5(1):57-65.

PMID: 38571932 PMC: 10985701. DOI: 10.1515/rir-2024-0007.


The role of ultrasonographic synovial assessment in rheumatoid arthritis patients with concomitant fibromyalgia.

Polat M, Kahveci A, Tecer D, Gunendi Z, Gogus F Arch Rheumatol. 2023; 38(2):174-182.

PMID: 37680511 PMC: 10481687. DOI: 10.46497/ArchRheumatol.2023.9585.


[Validation of the Pollard' s classification criteria (2010) for rheumatoid arthritis patients with fibromyalgia].

Gao C, Chen L, Wang L, Yao H, Huang X, Jia Y Beijing Da Xue Xue Bao Yi Xue Ban. 2022; 54(2):278-282.

PMID: 35435192 PMC: 9069046.


Rheumatoid arthritis activity scores in patients with and without fibromyalgia syndrome.

Durmaz Y, Ilhanli I Ann Saudi Med. 2021; 41(4):246-252.

PMID: 34420399 PMC: 8380282. DOI: 10.5144/0256-4947.2021.246.

References
1.
Strombeck B, Ekdahl C, Manthorpe R, Wikstrom I, Jacobsson L . Health-related quality of life in primary Sjögren's syndrome, rheumatoid arthritis and fibromyalgia compared to normal population data using SF-36. Scand J Rheumatol. 2000; 29(1):20-8. DOI: 10.1080/030097400750001761. View

2.
Sarmer S, Ergin S, Yavuzer G . The validity and reliability of the Turkish version of the Fibromyalgia Impact Questionnaire. Rheumatol Int. 2001; 20(1):9-12. DOI: 10.1007/s002960000077. View

3.
Naranjo A, Ojeda S, Francisco F, Erausquin C, Rua-Figueroa I, Rodriguez-Lozano C . Fibromyalgia in patients with rheumatoid arthritis is associated with higher scores of disability. Ann Rheum Dis. 2002; 61(7):660-1. PMC: 1754142. DOI: 10.1136/ard.61.7.660. View

4.
Fitzcharles M, Boulos P . Inaccuracy in the diagnosis of fibromyalgia syndrome: analysis of referrals. Rheumatology (Oxford). 2003; 42(2):263-7. DOI: 10.1093/rheumatology/keg075. View

5.
Kucukdeveci A, Sahin H, Ataman S, Griffiths B, Tennant A . Issues in cross-cultural validity: example from the adaptation, reliability, and validity testing of a Turkish version of the Stanford Health Assessment Questionnaire. Arthritis Rheum. 2004; 51(1):14-9. DOI: 10.1002/art.20091. View